Deferred Tax Assets, Valuation Allowance of 10x Genomics, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
10x Genomics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • 10x Genomics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $490,154,000, a 2.2% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

10x Genomics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $490,154,000 +$10,702,000 +2.2% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q4 2024 $479,452,000 +$36,378,000 +8.2% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q4 2023 $443,074,000 +$78,811,000 +22% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q4 2022 $364,263,000 +$51,069,000 +16% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q4 2021 $313,194,000 +$126,341,000 +68% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q4 2020 $186,853,000 +$120,397,000 +181% 31 Dec 2020 10-K 18 Feb 2022 2021 FY
Q4 2019 $66,456,000 +$10,783,000 +19% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q4 2018 $55,673,000 31 Dec 2018 10-K 27 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.